Boston Scientific And Angiotech Win Stent Suit

Law360, New York (May 4, 2006, 12:00 AM EDT) -- Medical device makers Boston Scientific Corp. and Angiotech Pharmaceuticals Inc. have emerged victorious in a patent dispute after a Dutch court ruled Sahajanand Medical Technologies Pvt. Ltd.’s drug-eluting stent violated two claims of an Angiotech patent.

The Dutch court confirmed that the Canadian drug company’s patent was valid and Sahajanand’s Infinnium paclitaxel-eluting stent infringed on it. India-based Sahajanand has been ordered to pay for damages as a result of the infringement.

The court also permitted an injunction against Sahajanand, barring the company from selling or delivering...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.